Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953647937> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2953647937 endingPage "S315" @default.
- W2953647937 startingPage "S315" @default.
- W2953647937 abstract "MGN is the second most common cause of nephrotic syndrome in adults, with FSGS recently becoming the most common, however there is no cure for idiopathic MGN and treatment focus on conservative methods such as salt restriction, blood thinning agents, ARB etc. Sometimes corticosteroids, cyclophosphamide, chlorambucil, cyclosporine-A, tacrolimus, MMF, Rituximab etc are tried with mixed results. Recently we have tried methylprednisolone pulse therapy in 7 cases and follow up renal biopsy were performed after 1 year of therapy. Age distribution from 1 to 61 (mean37) year old. Methylprednisolone pulse were tried by Cho’s method (Andreucci; New Therap Strat Nephrol, Kluwer Acad.Pub 1990). One cycle of MP pulse consist of methylprednisolone 20-30mg/kg (max1,000mg)/day mixed at 250ml amino acids solution for 3 consecutive days at 2 weeks interval. We tried 10 cycles. Between pulse therapy we tried deflazacort 0.5mg/kg/day and ARB were given every day. All 7 cases showed complete response clinically and complete dissolution of subepithelial deposits although sclerotic lesions were persisted pathologically. Two pediatric cases ages 1 and 7 showed completely cured clinically and pathologically. No major side effects were noted except one case developed cataract although minor side effects such as moon face, mild abdominal striae were noted. No relapses during 3 years follow up. In conclusion, further studies are needed. However methylprednisolone pulse therapy might be a promising initial treatment method in idiopathic MGN without noticeable side effects before considering secondary drugs such as alkylating agents, calcineurin inhibitors, Rituximab etc. Follow up renal biopsy is mandatory when deciding to stop oral steroid therapy." @default.
- W2953647937 created "2019-07-12" @default.
- W2953647937 creator A5031866717 @default.
- W2953647937 creator A5039729107 @default.
- W2953647937 creator A5049022688 @default.
- W2953647937 creator A5056690263 @default.
- W2953647937 creator A5065918494 @default.
- W2953647937 creator A5069969333 @default.
- W2953647937 creator A5070370233 @default.
- W2953647937 date "2019-07-01" @default.
- W2953647937 modified "2023-10-14" @default.
- W2953647937 title "MON-028 PATHOLOGICALLY PROVEN COMPLETE CURE OF IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS BY METHYLPREDNISOLONE PULSE THERAPY" @default.
- W2953647937 doi "https://doi.org/10.1016/j.ekir.2019.05.815" @default.
- W2953647937 hasPublicationYear "2019" @default.
- W2953647937 type Work @default.
- W2953647937 sameAs 2953647937 @default.
- W2953647937 citedByCount "1" @default.
- W2953647937 countsByYear W29536479372019 @default.
- W2953647937 crossrefType "journal-article" @default.
- W2953647937 hasAuthorship W2953647937A5031866717 @default.
- W2953647937 hasAuthorship W2953647937A5039729107 @default.
- W2953647937 hasAuthorship W2953647937A5049022688 @default.
- W2953647937 hasAuthorship W2953647937A5056690263 @default.
- W2953647937 hasAuthorship W2953647937A5065918494 @default.
- W2953647937 hasAuthorship W2953647937A5069969333 @default.
- W2953647937 hasAuthorship W2953647937A5070370233 @default.
- W2953647937 hasBestOaLocation W29536479371 @default.
- W2953647937 hasConcept C126322002 @default.
- W2953647937 hasConcept C141071460 @default.
- W2953647937 hasConcept C16005928 @default.
- W2953647937 hasConcept C2776694085 @default.
- W2953647937 hasConcept C2776715498 @default.
- W2953647937 hasConcept C2776755627 @default.
- W2953647937 hasConcept C2777866208 @default.
- W2953647937 hasConcept C2778720950 @default.
- W2953647937 hasConcept C2779338263 @default.
- W2953647937 hasConcept C2780372218 @default.
- W2953647937 hasConcept C2780653079 @default.
- W2953647937 hasConcept C71924100 @default.
- W2953647937 hasConcept C90924648 @default.
- W2953647937 hasConceptScore W2953647937C126322002 @default.
- W2953647937 hasConceptScore W2953647937C141071460 @default.
- W2953647937 hasConceptScore W2953647937C16005928 @default.
- W2953647937 hasConceptScore W2953647937C2776694085 @default.
- W2953647937 hasConceptScore W2953647937C2776715498 @default.
- W2953647937 hasConceptScore W2953647937C2776755627 @default.
- W2953647937 hasConceptScore W2953647937C2777866208 @default.
- W2953647937 hasConceptScore W2953647937C2778720950 @default.
- W2953647937 hasConceptScore W2953647937C2779338263 @default.
- W2953647937 hasConceptScore W2953647937C2780372218 @default.
- W2953647937 hasConceptScore W2953647937C2780653079 @default.
- W2953647937 hasConceptScore W2953647937C71924100 @default.
- W2953647937 hasConceptScore W2953647937C90924648 @default.
- W2953647937 hasIssue "7" @default.
- W2953647937 hasLocation W29536479371 @default.
- W2953647937 hasOpenAccess W2953647937 @default.
- W2953647937 hasPrimaryLocation W29536479371 @default.
- W2953647937 hasRelatedWork W2014368772 @default.
- W2953647937 hasRelatedWork W2049648051 @default.
- W2953647937 hasRelatedWork W2099178442 @default.
- W2953647937 hasRelatedWork W2360135782 @default.
- W2953647937 hasRelatedWork W2414149012 @default.
- W2953647937 hasRelatedWork W2908947106 @default.
- W2953647937 hasRelatedWork W3015876203 @default.
- W2953647937 hasRelatedWork W4212838170 @default.
- W2953647937 hasRelatedWork W4323898467 @default.
- W2953647937 hasRelatedWork W4413142 @default.
- W2953647937 hasVolume "4" @default.
- W2953647937 isParatext "false" @default.
- W2953647937 isRetracted "false" @default.
- W2953647937 magId "2953647937" @default.
- W2953647937 workType "article" @default.